Effectiveness of Intralesional Vitamin D3 in Cutaneous Warts
Keywords:
Cutaneous wart, immunotherapy, intralesional, cutaneous warts, vitamin D3Abstract
Background: Verruca vulgaris is a common viral infection of the skin caused by human papillomavirus that often causes significant discomfort and embarrassment. Several destructive methods are available for treatment with variable success and may result in scarring, while less aggressive approaches can lead to lesion recurrence. Additionally, these local modalities are not practical for patients with a large number of warts. Much research were performed to evaluate the various immunomodulators intralesionally to treat cutaneous warts. Intralesional vitamin D3 has been reported as a successful treatment of warts.
Aims: To evaluate the efficacy of intralesional vitamin D3 treatment for cutaneous warts.
Materials and Methods: This study considered 36 patients aged between 18 and 70 years who presented with single or multiple cutaneous warts, varying in size and duration, and who had not received immunosuppression drugs 6 months before starting this study. About 0.2 to 0.5 mL of vitamin D3 solution (600,000 IU; 15 mg/mL) was injected at the base of the wart following a lidocaine (0.2 mL, 20 mg/mL) injection. A maximum of 5 warts would be treated in a session set at 4 weeks for a maximum duration of 4 treatments until resolution. Both pre-and two-month post-intervention standardized photographs were taken. Patients were followed for 6 months after the last injection to see if they had any recurrence. Response was later categorized into complete, partial, or no response. Complete clearance of the injected wart target was recorded in 33.3% of patients in the case group, while only 5% of patients did so in the control group (p ≤.001), and that was statistically significant. Therefore, intralesional injection of vitamin D3 may be a plausible and safe intervention for treating common warts. Clinical assessment was by photographic evaluation at baseline, before and after each treatment session, and on completion of treatment.
The results are presented below. A total of 36 patients with cutaneous warts were included in the study. Of the total number of patients, 24 (66.7%) were male and 12 (33.3%) were female. Among the 36 patients, 22 (61.1%) had palmoplantar warts, 10 (27.8%) had common warts (verruca vulgaris), and 4 (11.1%) had filiform warts. The mean age of the patients was 34.31±11.33 years (range, 18 to 58 years). A total of 12 patients (33.3%) exhibited complete clearance of the warts. Out of the total 22 patients with palmoplantar warts, complete clearance was observed in 6 (27.3%). In the group of 4 patients with filiform warts, complete clearance was observed in 3 (75%). In the group of 10 patients with verruca vulgaris, complete clearance was observed in 3 (30%), completing the clearing process at the fourth visit. Thus, of the 36 patients, 12 (33.3%) exhibited a complete response, 8 (22.2%) demonstrated a moderate response, 7 (19.4%) displayed no response, and 9 (25%) were classified as non-responders. Recurrences were observed in six patients (16.7%). Among these, five patients (83.5%) who smoked exhibited a higher recurrence rate. No serious adverse effects were reported.
Conclusion: Intralesional injection of vitamin D3 may be considered safe, effective, well-tolerated, easily administrated in outpatient clinics and an inexpensive treatment and safe modality for the treatment of common warts.
Limitations: Small study samples and lack of a control group was the main drawbacks in our study.
References
Sterling JC, Handfield‑Jones S, Hudson PM; British Association of Dermatologists. Guidelines for the management of cutaneous warts. Br J Dermatol 2001; 144:4‑11.
Lynch MD, Cliffe J, Morris-Jones R. Management of cutaneous viral warts. BMJ 2014: 348:3339.
Vender R, Bourcier M, Bhatia N, Lynde C. Therapeutic options for external genital warts. J Cutan Med Surg 2013; 17 Suppl 2: 61–67
Gonçalves MA, Donadi EA. Immune cellular response to HPV: Current concepts. Braz J Infect Dis 2004; 8:1-9.
Gibbs S, Harvey I, Sterling J, Stark R. Local treatments for cutaneous warts: Systematic review. BMJ 2002; 325:461.
Savant SS, Gore D. Electrosurgery. In: Savant SS, Shah RA, Gore D, editors. Textbook and Atlas of Dermatosurgery and Cosmetology. Mumbai: ASCAD; 2005. p. 30514.
Bourke JF, Berth‑Jones J, Hutchinson PE. Cryotherapy of common viral warts at intervals of 1, 2, and 3 weeks. Br J Dermatol 1995; 132:4336.
Tan OT, Hurwitz RM, Stafford TJ. Pulsed dye laser treatment of recalcitrant verrucae: A preliminary report. Lasers Surg Med 1993; 13:12737
Allen AL, Siegfried EC. Management of warts and molluscum in adolescents. Adolesc Med 2001; 12:229–242.
Naglaa N. El Mongya, Rana F. Hilala, Amul M. Badrband Samah A. Alraawia. Serum vitamin D level in patients with viral warts. Journal of the Egyptian Women's Dermatologic Society 2018, 15:133–138
Rind T, Oiso N, Kawada A. Successful treatment of anogenital wart with a topical Vitamin D (3) Derivative in an infant. Case Rep Dermatol 2010; 2:46‑49.
Imagawa I, Suzuki H. Successful treatment of refractory warts with topical Vitamin D3 derivative (maxacalcitol, 1alpha,25‑dihydroxy‑22‑oxacalcitriol) in 17 patients. J Dermatol 2007; 34:2646.
Aktas H, Ergin C, Demir B, Ekiz Ö. Intralesional Vitamin D injection may be an effective treatment option for warts. J Cutan Med Surg 2016; 20:11822.
Kearns MD, Alvarez JA, Seidel N, Tangpricha V. The impact of vitamin D on infectious disease: a systematic review of controlled trials. Am J Med Sci2015; 349:245–262.
Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J, et al. Cutting edge: 1, 25-dihydroxy vitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 2004; 173:2909–2912.
Conner K, Nern K, Rudisill J, O’Grady T, Gallo RL. The antimicrobial peptide LL-37 is expressed by keratinocytes in condyloma acuminatum and verruca vulgaris. J Am Acad Dermatol 2002; 47: 347-50.
Meyer-Hoffert U, Schwarz T, Schröder JM, Gläser R. Expression of human beta-defensin-2 and -3 in verrucae vulgares and condylomata acuminata. J Eur Acad Dermatol Venereol 2008; 22 :1050-4.
Wang G. Human antimicrobial peptides and proteins. Pharmaceuticals 2014; 7: 545-94.
Beard JA, Bearden A, Striker R. Vitamin D, and the anti-viral state. J Clin Virol2011; 50:194–200.
Wang J, Lian H, Zhao Y, Kauss MA, Spindel S. Vitamin D3 induces autophagy of human myeloid leukemia cells. J Biol Chem 2008; 283:25596–25605.
Levine B, Mizushima N, Virgin HW. Autophagy in immunity and inflammation. Nature 2011; 469:323–325.
Kavya M, Shashikumar BM, Harish MR, Shweta BP. Safety and Efficacy of Intralesional Vitamin D3 in Cutaneous Warts: An Open Uncontrolled Trial. J Cutan Aesthet Surg. 2017 Apr-Jun; 10 (2):90-94
Khan Farhana, Anand J. Asia. Comparative Study of Therapeutic Efficacy of Intralesional Vitamin D3 versus Intralesional Purified Protein Derivative in the Treatment of Refractory Viral Warts at a Tertiary Referral Centre in Northern Maharashtra 2019, IJSR 8 (3): 1682-86
Shaheen MA, Salem SA, Fouad DA, El‑Fatah AA. Intralesional tuberculin (PPD) versus measles, mumps, rubella (MMR) vaccine in treatment of multiple warts: A comparative clinical and immunological study. Dermatol Ther 2015; 28:194‑200.
Majid I, Imran S. Immunotherapy with intralesional Candida albicans antigen in resistant or recurrent warts: A study. Indian J Dermatol 2013; 58:360‑5.
Lee JY, Kim CW, Kim SS. Preliminary study of intralesional bleomycin injection for the treatment of genital warts. Ann Dermatol 2015; 27:23941.
Singh S, Chouhan K, Gupta S. Intralesional immunotherapy with killed Mycobacterium indicus pranii vaccine for the treatment of extensive cutaneous warts. Indian J Dermatol Venereol Leprol 2014; 80:509‑14.
Coşkun öztekin, Aynure öztekin, Kenan Taştan, Gülsen Gül Özmen, Suzan Demir Pektaş. The Association Between Verruca Vulgaris And Vitamin D: Is There A Casuallink? Acta Medica Mediterranea, 2018, 34: 1047Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, et al. Toll‑like receptor triggering of a Vitamin D‑mediated human antimicrobial response. Science 2006; 311:17703.
Essam Elden M Mohameda, Moustafa A El Taiebb, Gehad A Abd El-Sabourb. Intralesional Vitamin D3 versus Purified Protein Derivatives in The Treatment of Multiple Cutaneous Warts: Comparative Study. The Egyptian Journal of Hospital Medicine (July 2019) Vol. 76 (2), Page 3589-3594
Ibrahim M Abdel Kareem, Ibrahim M Ibrahim, Sameh F Mohammed, Ahmed Abo-Bakr Ahmed. Effectiveness of intralesional vitamin D 3 injection in the treatment of common warts: Single-blinded placebo-controlled study, Dermatologic Therapy 2019, 32 (3): e12882
El-Taweel AE, Salem RM, Allam AH. Cigarette smoking reduces the efficacy of intralesional vitamin D in the treatment of warts. Dermatol Ther. 2019 Mar; 32 (2): e12816.
Raghu Kumar S, Ravikumar BC, Vinay KN, Suresh MR, Aggarwal A, Yashovardhana DP. Intralesional Vitamin D3 Injection in the Treatment of Recalcitrant Warts: A Novel Proposition. J Cutan Med Surg. 2017 Jul/Aug; 21 (4):320-324.
Muhammad K Shahzad, Ayesha Ambreen, Javed Iqbal. Efficacy Of Intralesional Vitamin D3 Therapy Versus Cryotherapy in The Treatment of Plantar Warts. IAJPS 2019, 06 (04), 7549-7553
Abd El-Magid WM, Nada EEA, Mossa RA. Treat Intralesional injection of vitamin D3 versus zinc sulfate 2% in the treatment of plantar warts: a comparative study. J Dermatolog 2019 Aug 29:1-6.
M. Naresh. A Study of Effectiveness of Intralesional Vitamin D3 in Treatment of Multiple Cutaneous Warts. IOSR Journal of Dental and Medical Sciences 2019, 18 (3): 84-87
Sushmalatha Banoth. Evaluation of therapeutic effectiveness of vitamin D3 injections in common warts in a tertiary care centre. Int J Res Dermatol 2019, 5 (3): 2134
Shaldoum DR, Hassan GFR, El Maadawy EH, El-Maghraby GM. Comparative clinical study of the efficacy of intralesional MMR vaccine vs. intralesional vitamin D injection in the treatment of warts. J Cosmet Dermatol. 2020 Jan 11. doi: 10.1111/jocd.13272.
Yousaf F., Raza, N., Ahmed, N., Sadiq, S., & Anwar, A. (2019). Comparison of Intralesional Vitamin D3 Versus Cryotherapy for Management of Plantar Warts. Pakistan Armed Forces Medical Journal, 69 (6), 1304-08.
Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, et al. Toll‑like receptor triggering of a Vitamin D‑mediated human antimicrobial response. Science 2006; 311:17703.
AlGhamdi K, Kumar A, Moussa N. The role of Vitamin D in melanogenesis with an emphasis on vitiligo. Indian J Dermatol Venereol Leprol 2013; 79:750‑8
